News

QT Imaging Holdings Announces Clearing of All Its Short-Term Liabilities and Forecasts Solid Revenue Growth

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) (the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce strengthening of its financials, by clearing its short-term liabilities and by forecasting solid revenue growth in 2025 and 2026. The Company announced amendments to both its convertible promissory note with YA II PN, Ltd. (the “YA Investor,” and such promissory note, t.

01/13/2025

QT Imaging Granted Renewal of NIH Sponsored Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the third year renewal of its five-year research grant from the National Institutes of Health (NIH)/National Cancer Institute (NCI). The study is a collaboration with the Department of Radiation Oncology, the Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toront.

10/29/2024

Profitability

Dividends

Income Statement

Balance Sheet

Cash Flow Statement

Symbol Frequently Asked Questions

Is QT Imaging Holdings, Inc. (QTI) a buy, sell, or hold?

QT Imaging Holdings, Inc. (QTI) can sell. Click on Rating Page for detail.

What is QT Imaging Holdings, Inc.'s stock price?

The price of QT Imaging Holdings, Inc. (QTI) is 0.4682 and it was updated on 2025-01-17 13:00:44.

Is QT Imaging Holdings, Inc. (QTI) overvalued or undervalued?

Currently QT Imaging Holdings, Inc. (QTI) is in undervalued.

News

From:

To:

News
QT Imaging Holdings Announces Favorable Amendment of Convertible Promissory Note NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce an amendment to its $10,000,000 convertible promissory note with YA II PN, Ltd. (the “Investor,” and such promissory note, the “Note”). On September 11, 2024, a trigger event associated with the share price of the company occurred under the terms of the Note. As a result, the company m. Mon, Sep. 30, 2024
QT Imaging Holdings Announces Participation in the IEEE International Ultrasonics Symposium, in Taipei, Taiwan NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce participation in the International Ultrasonics Symposium (IUS), an IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society conference, held in Taipei, Taiwan, on September 22-26, 2024. Dr. James Wiskin will represent QTI in the Medical Imaging subsection. The presentation focuss. Thu, Sep. 05, 2024
QTI Stock Earnings: QT Imaging Holdings Reported Results for Q2 2024 QT Imaging Holdings (NASDAQ: QTI ) just reported results for the second quarter of 2024. QT Imaging Holdings reported earnings per share of -30 cents. Mon, Aug. 26, 2024
QT Imaging Holdings' Technology Advances Medical Imaging Research at the University of Oklahoma's Health Stephenson Cancer Center NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is honored to partner with University of Oklahoma and OU Health Stephenson Cancer Center to advance and scale innovative research in medical imaging and to improve precision in cancer detection and treatment. University of Oklahoma (OU) is home to the National Cancer Institute (NCI) designated OU Health Steph. Mon, Jun. 24, 2024
QT Imaging Announces First Quarter 2024 Financial Results NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI) (“QT Imaging” or the “Company”), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced financial results for the first quarter of 2024. QT Imaging delivers today the QT Imaging Breast Acoustic CT™ Scanner, the only true 3D imaging device, FDA cleared for use as a transmission and reflection low frequency soundwaves imaging system for a patient's. Fri, May. 10, 2024

Press Releases

StockPrice Release
Qt imaging holdings announces clearing of all its short-term liabilities and forecasts solid revenue growth 01/13/2025
Qt imaging granted renewal of nih sponsored study for early identification of response of breast cancer patients to neoadjuvant chemotherapy 10/29/2024
Qt imaging holdings announces favorable amendment of convertible promissory note 09/30/2024
Qt imaging holdings announces participation in the ieee international ultrasonics symposium, in taipei, taiwan 09/05/2024
Qt imaging holdings' technology advances medical imaging research at the university of oklahoma's health stephenson cancer center 06/24/2024
Qt imaging announces first quarter 2024 financial results 05/10/2024
Qt imaging holdings announces partnership with premier cancer center, the vincere cancer center in scottsdale, az 05/08/2024
Qt imaging holdings (nasdaq: qti) to ring the nasdaq stock market opening bell 04/22/2024
Qt imaging announces second blinded screening trial finding its technology similarly effective as digital breast tomosynthesis 04/16/2024
Qt imaging's breast acoustic ct™ scanner to be offered at the center for new medicine to advance personalized prevention and detection of breast cancer 04/11/2024
Qt imaging holdings names dr. raluca dinu as acting chief executive officer and anastas budagov as chief financial officer 03/18/2024
Qt imaging holdings announces new ticker symbol for otc warrants and delisting of units 03/15/2024
Qt imaging's breast acoustic ct™ scanner used in study for early identification of response of breast cancer patients to neoadjuvant chemotherapy 03/14/2024
Qt imaging pioneers patient-centric breast imaging technology through strategic partnership 03/07/2024

More Headlines

News
QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) (“QT Imaging”) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with its strategic business and distribution partner, is proud to announce its partnership with The Vincere Cancer Center in Scottsdale, AZ. The Vincere Cancer Center is a top cancer center in the U.S. Founded by Dr. Vershalee Shukla and Dr. Pablo Prichard, the Center focuses on cancer. 05/08/2024
QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI), a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is proud to announce the Opening Bell Ceremony at the Nasdaq MarketSite in Times Square. In honor of the occasion, Dr. Raluca Dinu, Chief Executive Officer, will ring the Opening Bell. Where: Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio When: Tuesday, April 23rd, 2024 – 9:15 a. 04/22/2024
QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems is proud to announce positive data regarding the diagnostic performance of QTI's Breast Acoustic CTTM Scans for mass detection from its second blinded multi-reader multi-case study. The study was published in Academic Radiology, online, in January 2024: A Multireader Multicase (MRMC) Receiver Operating Charact. 04/16/2024
QT Imaging's Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, together with our strategic business and distribution partner are proud to announce their partnership with the Center of New Medicine in Irvine, California. The Center for New Medicine is one of the largest integrative medical clinics in North America, providing a personalized approach to health care includin. 04/11/2024
QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, today announced that the Board of Directors has appointed former GigCapital5, Inc. CEO Dr. Raluca Dinu as Active Chief Executive Officer and member of the Board of Directors, effective March 12, 2024. Dr. Dinu will serve in this position for one year, when the Company will reevaluate this strategic position. 03/18/2024
QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ: QTI), a medical device company engaged in the research, development, and commercialization of innovative body imaging systems, updated the ticker symbol for its warrants to “QTIWW”, currently trading in the over-the-counter (OTC) market, effective as of March 11, 2024. The company's units formerly trading in the OTC market under “GIAFU” have been delisted as of March 11, 2024, as each unit was split into one share of common sto. 03/15/2024
QT Imaging's Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy NOVATO, Calif.--(BUSINESS WIRE)--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the delivery of a Breast Acoustic CT™ Scanner under a unique collaboration with the Department of Radiation Oncology, and Radiation Treatment Program at the Sunnybrook Health Sciences Centre in Toronto, Canada, one of the largest cancer centers in Canada, and The University of Illinois,. 03/14/2024
QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership NOVATO, Calif.--(BUSINESS WIRE)---- $QTI--QT Imaging Holdings, Inc. (NASDAQ:QTI) a medical device company engaged in research, development, and commercialization of innovative body imaging systems, is pleased to announce the first commercial sale of a QTI Breast Acoustic CT™ System to True Health Center for Functional Medicine. QTI's inaugural customer was born as a result of the collaboration with our previously announced strategic distribution partner and represents the business model to be deployed b. 03/07/2024

Unlock

QTI Ratings Summary

QTI Quant Ranking

Is QT Imaging Holdings, Inc. (QTI) a buy, sell, or hold?

What is QT Imaging Holdings, Inc.'s stock price?

Is QT Imaging Holdings, Inc. (QTI) overvalued or undervalued?

QT Imaging Holdings Announces Partnership with Premier Cancer Center, The Vincere Cancer Center in Scottsdale, AZ

QT Imaging Holdings (Nasdaq: QTI) to Ring The Nasdaq Stock Market Opening Bell

QT Imaging Announces Second Blinded Screening Trial Finding Its Technology Similarly Effective as Digital Breast Tomosynthesis

QT Imaging's Breast Acoustic CT™ Scanner to be Offered at The Center for New Medicine to Advance Personalized Prevention and Detection of Breast Cancer

QT Imaging Holdings names Dr. Raluca Dinu as Acting Chief Executive Officer and Anastas Budagov as Chief Financial Officer

QT Imaging Holdings Announces New Ticker Symbol for OTC Warrants and Delisting of Units

QT Imaging's Breast Acoustic CT™ Scanner Used in Study for Early Identification of Response of Breast Cancer Patients to Neoadjuvant Chemotherapy

QT Imaging Pioneers Patient-Centric Breast Imaging Technology through Strategic Partnership

Company Details

Ratings

Quant Factor Grades

Trading

Dividend Grades

Dividend

Earnings

Valuation

Growth

Performance

Momentum

Profitability

Risk

Ownership

Debt